Drugs / Interferon alpha-2a recombinant
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1 | NCT02763969 Background | May → Dec 2016 | psoriasis | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 1 | NCT02534636 Background | Oct 2015 → Nov 2016 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon alpha-2a recombinant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02534636 ↗ |